Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes

Waleed F. Mourad, Daniel Shasha, Dukagjin M. Blakaj, Azita S. Khorsandi, Rania A. Shourbaji, Jonathan Glanzman, Rafi Kabarriti, Rebekah Young, Shyamal Patel, Evangelia Katsoulakis, Mauricio Gámez, Rudolph Woode, Cathy Lazarus, Kenneth S. Hu, Louis B. Harrison

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim: To investigate the impact of definitive radiation therapy (RT) in the management of early glottic cancer on clinical RT-induced dysphagia (RID) and carotid vasculopathy (RICV). Patients and Methods: This is a single-institution retrospective study. From January 1997 to 2010, 253 patients, with early glottic cancer, underwent RT with 60Co or LINAC-6 MV photons. RT fields with wedge pair and daily 5-mm bolus were applied in all patients treated with 6-MV photons to avoid under-dose of the anterior laryngeal structures. The whole larynx (LX), pharyngeal constrictors (PCs), and carotid arteries (CA) were contoured and dose-volume histograms (DVHs) were generated to assess the delivered dose. The median age of patients was 65 years (range; 28-93), Caucasians were 80%, males were 87%, and 23% had T2 lesions. Results: After a median follow-up of seven years (range; 1.5-12), the median dose and fraction size delivered to the LX were 63 and 2.25 Gy, respectively. The mean doses to the LX, PC, and CA were 57 Gy delivered to 34 cm3, 54 Gy to 15 cm3, and 60 Gy to 4 cm3, respectively. The LX, PC and CA V60 and V65 were (77 and 71), (70 and 52) and (84 and 51), respectively. Patients with acute dysphagia grades 1, 2, and 3 or more were 81, 19%, and zero, respectively; none had clinically RID or RICV. Conclusion: Small-volume RT up to 67.5 Gy at 2.25 Gy per fraction, is not a predictor of RID or RICV. Separate delineation of the aforementioned critical structures, as well as others, may better identify dose tolerances to maintain function and further prioritize the importance of structures in RID and RICV.

Original languageEnglish (US)
Pages (from-to)4483-4490
Number of pages8
JournalAnticancer Research
Volume33
Issue number10
StatePublished - Oct 1 2013
Externally publishedYes

Fingerprint

Deglutition Disorders
Larynx
Neck
Radiotherapy
Head
Carotid Arteries
Tongue Neoplasms
Photons
Retrospective Studies
RID

Keywords

  • Carotidvasculopathy
  • Constrictors
  • Early glottic cancer
  • Radiation induced dysphagia
  • Radiation therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mourad, W. F., Shasha, D., Blakaj, D. M., Khorsandi, A. S., Shourbaji, R. A., Glanzman, J., ... Harrison, L. B. (2013). Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes. Anticancer Research, 33(10), 4483-4490.

Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes. / Mourad, Waleed F.; Shasha, Daniel; Blakaj, Dukagjin M.; Khorsandi, Azita S.; Shourbaji, Rania A.; Glanzman, Jonathan; Kabarriti, Rafi; Young, Rebekah; Patel, Shyamal; Katsoulakis, Evangelia; Gámez, Mauricio; Woode, Rudolph; Lazarus, Cathy; Hu, Kenneth S.; Harrison, Louis B.

In: Anticancer Research, Vol. 33, No. 10, 01.10.2013, p. 4483-4490.

Research output: Contribution to journalArticle

Mourad, WF, Shasha, D, Blakaj, DM, Khorsandi, AS, Shourbaji, RA, Glanzman, J, Kabarriti, R, Young, R, Patel, S, Katsoulakis, E, Gámez, M, Woode, R, Lazarus, C, Hu, KS & Harrison, LB 2013, 'Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes', Anticancer Research, vol. 33, no. 10, pp. 4483-4490.
Mourad WF, Shasha D, Blakaj DM, Khorsandi AS, Shourbaji RA, Glanzman J et al. Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes. Anticancer Research. 2013 Oct 1;33(10):4483-4490.
Mourad, Waleed F. ; Shasha, Daniel ; Blakaj, Dukagjin M. ; Khorsandi, Azita S. ; Shourbaji, Rania A. ; Glanzman, Jonathan ; Kabarriti, Rafi ; Young, Rebekah ; Patel, Shyamal ; Katsoulakis, Evangelia ; Gámez, Mauricio ; Woode, Rudolph ; Lazarus, Cathy ; Hu, Kenneth S. ; Harrison, Louis B. / Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes. In: Anticancer Research. 2013 ; Vol. 33, No. 10. pp. 4483-4490.
@article{b2cc3d0d483c47f3adce35bc413ebaba,
title = "Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes",
abstract = "Aim: To investigate the impact of definitive radiation therapy (RT) in the management of early glottic cancer on clinical RT-induced dysphagia (RID) and carotid vasculopathy (RICV). Patients and Methods: This is a single-institution retrospective study. From January 1997 to 2010, 253 patients, with early glottic cancer, underwent RT with 60Co or LINAC-6 MV photons. RT fields with wedge pair and daily 5-mm bolus were applied in all patients treated with 6-MV photons to avoid under-dose of the anterior laryngeal structures. The whole larynx (LX), pharyngeal constrictors (PCs), and carotid arteries (CA) were contoured and dose-volume histograms (DVHs) were generated to assess the delivered dose. The median age of patients was 65 years (range; 28-93), Caucasians were 80{\%}, males were 87{\%}, and 23{\%} had T2 lesions. Results: After a median follow-up of seven years (range; 1.5-12), the median dose and fraction size delivered to the LX were 63 and 2.25 Gy, respectively. The mean doses to the LX, PC, and CA were 57 Gy delivered to 34 cm3, 54 Gy to 15 cm3, and 60 Gy to 4 cm3, respectively. The LX, PC and CA V60 and V65 were (77 and 71), (70 and 52) and (84 and 51), respectively. Patients with acute dysphagia grades 1, 2, and 3 or more were 81, 19{\%}, and zero, respectively; none had clinically RID or RICV. Conclusion: Small-volume RT up to 67.5 Gy at 2.25 Gy per fraction, is not a predictor of RID or RICV. Separate delineation of the aforementioned critical structures, as well as others, may better identify dose tolerances to maintain function and further prioritize the importance of structures in RID and RICV.",
keywords = "Carotidvasculopathy, Constrictors, Early glottic cancer, Radiation induced dysphagia, Radiation therapy",
author = "Mourad, {Waleed F.} and Daniel Shasha and Blakaj, {Dukagjin M.} and Khorsandi, {Azita S.} and Shourbaji, {Rania A.} and Jonathan Glanzman and Rafi Kabarriti and Rebekah Young and Shyamal Patel and Evangelia Katsoulakis and Mauricio G{\'a}mez and Rudolph Woode and Cathy Lazarus and Hu, {Kenneth S.} and Harrison, {Louis B.}",
year = "2013",
month = "10",
day = "1",
language = "English (US)",
volume = "33",
pages = "4483--4490",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "10",

}

TY - JOUR

T1 - Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes

AU - Mourad, Waleed F.

AU - Shasha, Daniel

AU - Blakaj, Dukagjin M.

AU - Khorsandi, Azita S.

AU - Shourbaji, Rania A.

AU - Glanzman, Jonathan

AU - Kabarriti, Rafi

AU - Young, Rebekah

AU - Patel, Shyamal

AU - Katsoulakis, Evangelia

AU - Gámez, Mauricio

AU - Woode, Rudolph

AU - Lazarus, Cathy

AU - Hu, Kenneth S.

AU - Harrison, Louis B.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Aim: To investigate the impact of definitive radiation therapy (RT) in the management of early glottic cancer on clinical RT-induced dysphagia (RID) and carotid vasculopathy (RICV). Patients and Methods: This is a single-institution retrospective study. From January 1997 to 2010, 253 patients, with early glottic cancer, underwent RT with 60Co or LINAC-6 MV photons. RT fields with wedge pair and daily 5-mm bolus were applied in all patients treated with 6-MV photons to avoid under-dose of the anterior laryngeal structures. The whole larynx (LX), pharyngeal constrictors (PCs), and carotid arteries (CA) were contoured and dose-volume histograms (DVHs) were generated to assess the delivered dose. The median age of patients was 65 years (range; 28-93), Caucasians were 80%, males were 87%, and 23% had T2 lesions. Results: After a median follow-up of seven years (range; 1.5-12), the median dose and fraction size delivered to the LX were 63 and 2.25 Gy, respectively. The mean doses to the LX, PC, and CA were 57 Gy delivered to 34 cm3, 54 Gy to 15 cm3, and 60 Gy to 4 cm3, respectively. The LX, PC and CA V60 and V65 were (77 and 71), (70 and 52) and (84 and 51), respectively. Patients with acute dysphagia grades 1, 2, and 3 or more were 81, 19%, and zero, respectively; none had clinically RID or RICV. Conclusion: Small-volume RT up to 67.5 Gy at 2.25 Gy per fraction, is not a predictor of RID or RICV. Separate delineation of the aforementioned critical structures, as well as others, may better identify dose tolerances to maintain function and further prioritize the importance of structures in RID and RICV.

AB - Aim: To investigate the impact of definitive radiation therapy (RT) in the management of early glottic cancer on clinical RT-induced dysphagia (RID) and carotid vasculopathy (RICV). Patients and Methods: This is a single-institution retrospective study. From January 1997 to 2010, 253 patients, with early glottic cancer, underwent RT with 60Co or LINAC-6 MV photons. RT fields with wedge pair and daily 5-mm bolus were applied in all patients treated with 6-MV photons to avoid under-dose of the anterior laryngeal structures. The whole larynx (LX), pharyngeal constrictors (PCs), and carotid arteries (CA) were contoured and dose-volume histograms (DVHs) were generated to assess the delivered dose. The median age of patients was 65 years (range; 28-93), Caucasians were 80%, males were 87%, and 23% had T2 lesions. Results: After a median follow-up of seven years (range; 1.5-12), the median dose and fraction size delivered to the LX were 63 and 2.25 Gy, respectively. The mean doses to the LX, PC, and CA were 57 Gy delivered to 34 cm3, 54 Gy to 15 cm3, and 60 Gy to 4 cm3, respectively. The LX, PC and CA V60 and V65 were (77 and 71), (70 and 52) and (84 and 51), respectively. Patients with acute dysphagia grades 1, 2, and 3 or more were 81, 19%, and zero, respectively; none had clinically RID or RICV. Conclusion: Small-volume RT up to 67.5 Gy at 2.25 Gy per fraction, is not a predictor of RID or RICV. Separate delineation of the aforementioned critical structures, as well as others, may better identify dose tolerances to maintain function and further prioritize the importance of structures in RID and RICV.

KW - Carotidvasculopathy

KW - Constrictors

KW - Early glottic cancer

KW - Radiation induced dysphagia

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=84891351747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891351747&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 4483

EP - 4490

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 10

ER -